Results

Total Results: 74 records

Showing results for "venous".

21. Archived: Iron Deficiency Anemia in Pregnant Women and Young Children: Screening and Supplementation, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/iron-deficiency-anemia-pregnant-women-young-children-screening-supplementation-1996
    January 01, 1996 - for infant testing, results obtained from capillary blood specimens are less reliable than those from venous … microhematocrit to have a sensitivity of 90% and a specificity of 44% when compared with values obtained from venous … Although capillary blood specimens are easier to obtain in infants, a venous blood count provides more

22. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
    April 15, 2013 - A recent meta-analysis of tamoxifen trials indicated that risks for endometrial cancer, deep venous thrombosis … women indicated that breast cancer (69%), pulmonary embolism (67%), endometrial cancer (63%), and deep venous … Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention … Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. … 1.67) ¶¶ 3 - - 0.93 (0.84–1.04) 2 - - CHD = coronary heart disease; DVT = deep venous

23. Final Recommendation Statement: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - Tamoxifen and raloxifene increase risk for venous thromboembolic events (VTEs); tamoxifen increases risk … Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. … Nonvertebral 3 (0.2-5) ND ND Harms: Events Increased (95% CI) a Vascular    Venous

24. Recommendation: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - Tamoxifen and raloxifene increase risk for venous thromboembolic events (VTEs); tamoxifen increases risk … Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. … Nonvertebral 3 (0.2-5) ND ND Harms: Events Increased (95% CI) a Vascular    Venous

25. Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review of the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/7ZSKduUYHWKe7q_tTY9xbF
    April 01, 2013 - A recent meta-analysis of tamoxifen trials indicated that risks for endometrial can- cer, deep venous … women indicated that breast cancer (69%), pulmonary embolism (67%), endometrial cancer (63%), and deep venous … Effect of tamoxifen on venous thrombo- embolic events in a breast cancer prevention trial. … Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention … tamoxifen 1.25 (0.93–1.67)¶¶ 3 – – 0.93 (0.84–1.04) 2 – – CHD � coronary heart disease; DVT � deep venous

26. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/3Kwu7j_WfCFQSnSzqrDWwt
    June 20, 2019 - Tamoxifen and ral- oxifene increase risk for venous thromboembolic events (VTEs); ta- moxifen increases … Vertebral ND 7 (5-9) ND Nonvertebral 3 (0.2-5) ND ND Harms: Events Increased (95% CI)c Vascular Venous … Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.

27. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-myocardial-infarction-preventive-medication-1996
    January 01, 1996 - Collaboration Collaborative overview of randomised trials of antiplatelet therapy—III: reduction in venous

28. Archived: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
    March 14, 2014 - TC and HDL-C can be measured accurately on nonfasting venous or capillary blood samples, but LDL-C requires

29. PII: S0749-3797(01)00266-5 (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/aJ-xmGLsKqLQbQsBqodKZ5
    January 01, 2001 - TC and HDL-C can be measured accurately on nonfasting venous or capillary blood samples, but LDL-C requires

30. Archived: Gestational Diabetes Mellitus: Screening, 2003 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-mellitus-screening-2003
    February 01, 2003 - Two thresholds for an abnormal screen have been proposed by different experts: A venous plasma glucose

31. Screening for Iron Deficiency Anemia--Including Iron Supplementation for Children and Pregnant Women (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/c7NQCTUxonKVCR_B8nGq9y
    May 01, 2006 - Premature and low birth weight infants are also at increased risk for iron deficiency. 3 • Venous

32. Archived: Iron Deficiency Anemia: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/iron-deficiency-anemia-screening-2006
    May 15, 2006 - Venous hemoglobin is more accurate than capillary hemoglobin for identifying anemia.

33. Archived: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening-june-2018
    June 26, 2018 - Health Initiative trial, the previous review found an increased rate of gallbladder events, stroke, and venous … invasive breast cancer, coronary heart disease, probable dementia, gallbladder events, stroke, and venous

34. Archived: Carotid Artery Stenosis: Screening, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening-1996
    January 01, 1996 - compromise in blood flow 14 similar sounds can also be produced by anatomic variation and tortuosity, venous

35. Archived: Osteoporosis: Screening, 2002 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening-2002
    September 17, 2002 - Harms of hormone replacement therapy include venous thromboembolic events, endometrial cancer, and cholecystitis

36. Chemo and Couns/2nd instal (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/-hnLT26c2NHs6thK9yznPF
    July 01, 2002 - The relative risk increase in venous thromboembolism from tamoxifen or raloxifene does not appear to … Risk of venous thromboembolism in users of hormone replacement therapy.

37. PII: S0749-3797(01)00255-0 (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/yw_rbA_nQrCnkaN8X5t56S
    January 01, 2001 - Reliability of Screening Tests TC measurements from venous blood samples gener- ally have good reliability … so-called “point of care” testing) appear to have similar reliability under optimal condi- tions to venous

38. Archived: Evidence Summary: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
    April 09, 2001 - Reliability of Screening Tests TC measurements from venous blood samples generally have good reliability … (so-called “point of care” testing) appear to have similar reliability under optimal conditions to venous

39. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
    May 06, 2002 - The relative risk increase in venous thromboembolism from tamoxifen or raloxifene does not appear to … Risk of venous thromboembolism in users of hormone replacement therapy.

40. Screening for Osteoporosis in Postmenopausal Women - Recommendations and Rationale (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/nnkwqkX-Nk6v3gsphVATUD
    September 01, 2002 - Harms of hormone replacement therapy include venous thromboembolic events, endometrial cancer, and cholecystitis